BioTime, Inc. (NYSE MKT:BTX) Q3 2018 Earnings Conference Call Transcript
Nov 08, 2018 • 04:30 pm ET
Welcome to BioTime, Inc.'s Third Quarter 2018 Conference Call. At this time all participants are in a listen-only mode. An audio webcast of this call is available on the investor's section of BioTime's website at www.biotimeinc.com. This call is subject to copyright property of BioTime, Inc. and recording, reproduction or transmission of this call without expressed written consent of BioTime is strictly prohibited. As a reminder, today's call is being recorded. I would now like to introduce your host for today's conference, Ioana Hone of BioTime Investor Relations. Ms. Hone, please go ahead.
Thank you, Tiffany. Good morning, and thank you for joining us. My name is Ioana Hone, and I am responsible for Investor Relations at BioTime, and it is a pleasure to be with you today. A press release reporting our third quarter 2018 financial results was issued earlier today, November 8th, 2018 and can be found on the Investor Section of our website. (Forward-Looking Cautionary Statements). Joining us today are our newly appointed CEO, Brian Culley; our CFO, Russell Skibsted; and our SVP of Clinical and Medical Affairs, Gary Hogge. The executives will provide prepared remarks, then take questions from analysts and institutional holders. With that, I'd like to turn the call over to Brian Culley, who joined BioTime as its new CEO on September 17th.